MDA‑MB‑231 is a human triple-negative breast cancer (TNBC) cell line widely used in cancer research and drug discovery. These cells are mesenchymal-like, highly invasive, and adherent, making them an excellent model for studying tumor progression, metastasis, epithelial-to-mesenchymal transition (EMT), and therapeutic response. MDA‑MB‑231 cells are commonly employed in preclinical studies, signaling pathway research, and screening of anti-cancer compounds, providing a robust platform for both basic and translational research.
The cells should be handled at laboratory containment level 1.